PRESS RELEASE: NuLiv Science Awarded Natural Product Number (NPN) from Health Canada to Expand Skin Health Ingredient, Astrion™, into Canadian Market
BREA, CA – Nuliv Science announced that its patented ingredient, Astrion™, has received a Natural Product Number (NPN) from Health Canada. This is a significant milestone for the company and demonstrates the safety and effectiveness of Astrion™ as a natural health product.
Astrion™ is a unique compound of plant-based ingredients, Centella asiatica and Astragalus membranaceus, that has been clinically shown to support skin health.
“We are thrilled to receive the NPN for Astrion™,” said Richard Wang, CEO of Nuliv Science. “This is a testament to the safety, quality, and effectiveness of our ingredient. We are committed to bringing the best natural health solutions to our customers, and the NPN is a reflection of our dedication to producing high-quality ingredients.“
The NPN is granted by Health Canada to natural health products that have been assessed for safety, efficacy, and quality. It is a valuable tool for consumers to identify products that meet Health Canada’s strict standards for natural health products.
With the NPN, Nuliv Science can now market Astrion™ as a natural health product in Canada, further expanding the company’s reach.
“We are confident that Astrion™ will continue to be a valuable addition to the natural health product market and we look forward to sharing its benefits with even more people.”, added Wang.
ABOUT NULIV SCIENCE
Nuliv Science, a Certified B-Corp, specializes in the research and development of patented nutraceutical ingredients via traditional and Western scientific methods. Since 1997, the company has served our clients’ sourcing and research needs with an emphasis on quality and efficacy.
Our clientele base, from large MLMs and global sports nutrition brands to natural health practitioners, is as diverse as our ingredient portfolio. NuLiv Science’s experienced research team and network of scientific advisors can help with formulations, efficacy, standardization analytics, and the production of high-potency extracts.
Josh Beaty, Marketing Director